RNA Therapeutics Market is estimated to be US$ 2.77 billion by 2030 with a CAGR of 7.50% during the forecast period

Download Sample

Published Date: April 2023

RNA Therapeutics Market accounted for US$ 1.35 billion in 2020 and is estimated to be US$ 2.77 billion by 2030 and is anticipated to register a CAGR of 7.50%. RNA Therapeutics are a rapidly growing class of pharmaceuticals that will accelerate the development of new treatments, enable personalised therapy, and render the term "undruggable" obsolete. The first RNA medications have been approved, and a large number of others are in the works. We are in the midst of a therapeutic revolution unseen since the introduction of recombinant protein technology in Silicon Valley about 50 years ago. Recent improvements in the production, purification, and transport of RNA to cells have paved the way for the development of RNA-based therapies for a wide range of uses. RNA therapies are a rapidly growing class of medications that will revolutionize the treatment of numerous diseases and enable personalized therapy.

The report " Global RNA Therapeutics Market, By Technology (RNA Interference, and Antisense RNA), By Route of Administration (Pulmonary Delivery, Intravenous Injections, Intra-dermal Injections, Topical Delivery and Others), By Indications (Oncology, CVDs, Respiratory Disorders, Neurological Disorders, Infectious Disorders and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’

Key Highlights:

Agilent Technologies released the SureSelect XT HS2 RNA Reagent Kit in 2020.
Merck KGaA is investing USD 21.32 million in a new Life Science Laboratory in Switzerland for the year 2020.
Agilent plans to invest USD 150 million in Colorado in 2020 to boost its manufacturing capacity for nucleic acid-based therapies.
Agilent and SomaLogic signed an agreement in 2019 under which Agilent would provide customised high-fidelity oligo microarrays for use in SomaLogic's innovative SOMAscan assay's nucleic acid detection phases.

Analyst View:

Antisense and RNAi therapies can be used to treat a variety of disorders that impact the cell growth cycle and target nucleic acids. The ability of miRNA to restore gene expression and correct protein production, consequently impacting industrial advancement, is receiving a lot of attention. Research into the use of various pathways to deliver the intended impact of the candidate moiety before it is removed from the blood is expected to boost sector expansion.

Browse 60 market data tables and 35 figures* through 140 slides and in-depth TOC on “*Global RNA Therapeutics Market, By Technology (RNA Interference, and Antisense RNA), By Route of Administration (Pulmonary Delivery, Intravenous Injections, Intra-dermal Injections, Topical Delivery and Others), By Indications (Oncology, CVDs, Respiratory Disorders, Neurological Disorders, Infectious Disorders and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Market Insights from the report:

Global RNA Therapeutics Market accounted for US$ 1.35 billion in 2020 and is estimated to be US$ 2.77 billion by 2030 and is anticipated to register a CAGR of 7.50%. The Global RNA Therapeutics Market is segmented based on technology, route of administration, indication and region.

Based on Technology, Global RNA Therapeutics Market is segmented into RNA Interference, and Antisense RNA.
Based on Route of Administration, Global RNA Therapeutics Market is segmented into Pulmonary Delivery, Intravenous Injections, Intra-dermal Injections, Topical Delivery and Others.
Based on Indication, Global RNA Therapeutics Market is segmented into Oncology, CVDs, Respiratory Disorders, Neurological Disorders, Infectious Disorders and Others.
By Region, the Global RNA Therapeutics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Global RNA Therapeutics Market:

Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US). Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period